NeoPharm Reports Third-Quarter 2006 Financial Results And Accomplishments
WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (Nasdaq:NEOL):
2006 third-quarter net loss reduced 24% to $8.0 million vs. prior year quarter
Third-quarter cash use reduced 35% to $5.4 million vs. prior year quarter
Company reduces full-year 2006 expense guidance